Drug Type CAR-NK |
Synonyms- |
Target |
Action inhibitors, modulators |
Mechanism CD33 inhibitors(Myeloid cell surface antigen CD33 inhibitors), CLL-1 modulators(C-Type lectin domain family 12 member A modulators), Immunologic cytotoxicity |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingEarly Phase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Myeloid Leukemia | Phase 1 | China | 03 Jun 2021 |